Price $142.50 |
Market Cap
17.75B
|
Sector Health Care |
Div. Growth
7.00%
|
|
P/E
8.5
|
P/B
3.04
|
P/S
1.62
|
Dividend %
1.70%
|
|
P/CF
-
|
P/FCF
10.3
|
Op. Cash Flow
2.59M
|
FCF
13.8
|
|
Op. Margin
24.50%
|
Net Margin
20.20%
|
ROE
34.70%
|
ROI
13.80%
|
|
ROA
16.30%
|
EPS Growth
203.10%
|
Current Ratio
1.7
|
Debt/Equity
59.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $6.84 | - | - | 284.5M | Strong Buy |
| ConforMIS Inc (CFMS) | $1.23 | - | - | 247.3M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.41 | - | - | 15.9M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.68 | - | - | 110.9M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.14 | - | - | 50.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
